CSIMarket
 
Progyny Inc   (PGNY)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 
Price: $15.7300 $-0.37 -2.298%
Day's High: $16.13 Week Perf: -3.62 %
Day's Low: $ 15.54 30 Day Perf: -34.87 %
Volume (M): 2,597 52 Wk High: $ 42.08
Volume (M$): $ 40,856 52 Wk Avg: $30.55
Open: $16.13 52 Wk Low: $13.93



 Market Capitalization (Millions $) 1,539
 Shares Outstanding (Millions) 98
 Employees 197
 Revenues (TTM) (Millions $) 1,131
 Net Income (TTM) (Millions $) 63
 Cash Flow (TTM) (Millions $) -76
 Capital Exp. (TTM) (Millions $) 3

Progyny Inc
Progyny Inc is a leading provider of employer-sponsored fertility benefits and care.
The company provides comprehensive fertility solutions to self-insured employers, large enterprises, and employees, addressing the broad range of needs individuals face when seeking fertility care.
It uses advanced technology and data analytics to provide personalized care plans and cost-effective, evidence-based treatments.
Progyny's mission is to provide support, education, and assistance to individuals struggling to achieve their dream of starting a family.
Its emphasis on personalized care plans and proactive guidance sets it apart from traditional fertility benefits providers.
The company has developed strong partnerships with top-tier fertility clinics, enabling it to offer the latest and most advanced treatments to its patients.
With a robust portfolio of services, Progyny offers a full suite of fertility benefits, including fertility assessments, FDA-approved medications, egg freezing, in-vitro fertilization (IVF), genetic testing, and surrogacy services.
Its proprietary platform, called "PURE," provides members with easy access to patient-centric care and support services, including telemedicine consultations with fertility specialists, virtual support groups, and personalized health coaching.
Progyny's innovative approach to fertility care has earned it several accolades, including being named one of the "50 Smartest Companies" by MIT Technology Review and one of the "Most Innovative Companies" in healthcare by Fast Company.
The company has also been recognized for its emphasis on employee well-being, earning multiple awards and recognition for being a great place to work.
Overall, Progyny Inc is a rapidly-growing company that's reshaping the fertility benefits industry by providing a comprehensive suite of personalized care services to individuals seeking to start families.
Its focus on innovative technology, a broad network of high-quality clinics, and a patient-centric approach provides members with the support and resources they need to achieve their fertility goals.


   Company Address: 1359 Broadway New York 10018 NY
   Company Phone Number: 888-3124   Stock Exchange / Ticker: NASDAQ PGNY


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Merger and Acquisition

Progyny, Inc. Amplifies Worldwide Services by Acquiring Apryl, a Berlin-based Fertility Benefits Platform

Published Mon, Jun 24 2024 11:00 AM UTC


New York, June 24, 2024 - Progyny, Inc. (Nasdaq: PGNY), a leading fertility, family building, and women's health benefits solution, has made a significant stride towards expanding its global offerings with the recent acquisition of Apryl, a fertility benefits platform based in Berlin. The acquisition marks an important milestone for Progyny, as it further strengthens th...

Progyny Inc

Progyny Inc. Defies Economic Downturn with Record Profits in First Quarter of 2024

In a momentous collaboration, Progyny Inc and Fertility Matters Canada have joined forces to shed light on the challenges faced by millions of individuals and couples in need of family building care. As part of their efforts, the organizations will be hosting a special event that brings together leading providers, employers, and fertility advocates in Canada. The aim of this event is to show support and raise awareness for the millions of people in Canada who require access to essential reproductive services.
For years, Canadians have been grappling with limited access to fertility treatments and family-building care, causing significant emotional, physical, and financial distress for those trying to conceive. The partnership between Progyny Inc and Fertility Matters Canada during Canadian Fertility Awareness Week intends to showcase these issues and initiate important conversations with stakeholders to drive positive change.

Partnership

Progyny and Fertility Matters Canada Collaborate to Champion Expanded Access to Family Building Care in Canadian Fertility Awareness Week

Published Wed, Apr 17 2024 1:24 PM UTC

In a remarkable show of support, Progyny and Fertility Matters Canada, two leading organizations in the field of fertility care, have come together to recognize and advocate for Canadian Fertility Awareness Week. This joint effort aims to raise awareness about the challenges faced by millions of individuals and couples in need of family building care across the country. As t...

Progyny Inc

Progyny Inc. Reports Extraordinary Financial Performance in Q4 2023

Progyny Inc. has recently made headlines in the stock market with its impressive financial performance in the fourth quarter of 2023, showcasing substantial growth in both income per share and revenue. The company reported a significant increase in income per share by 339.82% year on year, soaring to $0.13 per share, and a revenue growth of 26.045% to $270.14 million. These numbers indicate a positive trajectory for the company, marking a notable improvement from the preceding period.
Furthermore, Progyny Inc. also reported a remarkable increase in net profits in the fourth quarter of 2023 earnings season, showing a staggering 295.25% growth from the same period a year ago. The company emphasized its improving profit margins, with net margin rising to 4.99% and operating margin edging up to 5.11%. Operating earnings also saw a substantial rise of 317.42% to $13.8 million.

Stock Market Announcement

Progyny, Inc. Implements Share Repurchase Program to Strengthen Investor Confidence

Published Thu, Feb 29 2024 12:30 PM UTC



Progyny, Inc. (Nasdaq: PGNY) recently announced its Board of Directors' approval of a share repurchase program, allowing the company to buy back up to $100 million of its common stock. This move reflects the company's commitment to enhancing shareholder value and improving investor sentiment. In this article, we will outline the key facts surrounding this announcem...







Progyny Inc's Segments





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com